Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP)
Post# of 721
(Total Views: 146)
Posted On: 11/07/2017 6:25:45 PM
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Supplements Popular Beverage with Legal CBD
- Unique patented drug delivery platform
- Active in world’s largest beverage market
- Technology that compliments rather than competes with CBD companies
An old and popular beverage is being supplemented in a healthy, flavorful way now that Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is on the scene. Having increased its ownership stake in PoViva Tea, LLC from 51% to 100%, the innovative drug delivery biotech plans to apply its patented DehydraTECH™ technology to supplement a range of black teas with cannabidiol (CBD) from hemp. After water, tea is the most widely consumed beverage in the world and is an ideal adjuvant to speed adoption of CBD supplements. Now that it is complementing the recognized virtues of tea with the therapeutic benefits of CBD, Lexaria is poised to revolutionize the age-old ritual of afternoon tea.
America is a nation of tea drinkers. In 2016, Americans drank 84 billion cups of tea; that is 260 cups for every man, woman and child. Of the 3.8 billion gallons thus consumed, about 80% was black tea, 16% was green tea, while the rest was either Oolong, white or dark tea. Unlike the rest of the world, Americans like their tea cold. About 80 percent of the tea consumed on a daily basis is chilled. However, hot tea appears to be gaining in popularity with the health conscious. The Tea Association of the USA reports (http://nnw.fm/t7Rn7) that ‘total category sales for hot tea have increased more than 15% over the last 5 years…’ The Association ‘anticipates strong, continuous growth, with a CAGR of 4-6% (coming) from all segments driven by variety, convenience, health benefits, sustainability, availability, continued innovation and the discovery of unique, flavorful and high-end specialty teas’.
Lexaria’s acquisition of Poviva Tea, LLC, announced on November 2 (http://nnw.fm/CQpn9), gives Lexaria a toehold in this vast $7 billion plus market and consolidates ownership of Poviva Tea, LLC as a wholly owned Lexaria Bioscience subsidiary. The move also simplifies future operations and certain intellectual property ownership issues. In addition, Lexaria announced that, effectively immediately, PoViva Tea will now operate with the trade name of ViPovaTM Tea. The company believes that the rebranding will ensure long-term protection of intellectual rights. At the center of this strategy is Lexaria’s patented DehydraTECH technology, which is focused on the improving the delivery of many commonly used Active Pharmaceutical Ingredients (APIs). The DehydraTECH technology provides an additional layer of effectiveness, designed to harmonize with the intellectual property of third parties, which both patented and generic API substances can employ. Lexaria’s long term strategy is to partner with the world’s leading firms as they deliver best-of-class products to their existing large consumer groups.
Lexaria is constantly exploring ways to make the health benefits of cannabinoids (CBD) more accessible and the company’s DehydraTECH technology is a way to do so. Many hemp products on the market are simply mixtures of hemp oil with other ingredients. However, Lexaria’s patented methodology infuses organically sourced hemp oil into the molecules of other substances, such as lipids, which, as it turns out, form the basis of the human endocannabinoid system. Consequently, the body better absorbs products employing the technology.
Presently, Lexaria is the only company in the world that has been awarded a patent for the improved (oral or ingestible, including pills) delivery of all non-psychoactive cannabinoids. Patents have been awarded in the U.S. and Australia and are pending in 40 more countries. This puts the company in the unusually advantageous position of owning proprietary technology that can deliver a vast range of non-psychoactive cannabinoid-based drugs.
Lexaria is already applying its innovative delivery technology to the range of ViPova black teas, which come from the province of Yunnan in China and are supplemented with hemp oil infused within dried evaporated non-fat milk. Introduced in January 2015, the tea is available in a variety of varieties and flavors. The ViPova range runs from 8 to 32 bag portions and varieties include Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light.
For more information, visit the company’s website at www.LexariaEnergy.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Unique patented drug delivery platform
- Active in world’s largest beverage market
- Technology that compliments rather than competes with CBD companies
An old and popular beverage is being supplemented in a healthy, flavorful way now that Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is on the scene. Having increased its ownership stake in PoViva Tea, LLC from 51% to 100%, the innovative drug delivery biotech plans to apply its patented DehydraTECH™ technology to supplement a range of black teas with cannabidiol (CBD) from hemp. After water, tea is the most widely consumed beverage in the world and is an ideal adjuvant to speed adoption of CBD supplements. Now that it is complementing the recognized virtues of tea with the therapeutic benefits of CBD, Lexaria is poised to revolutionize the age-old ritual of afternoon tea.
America is a nation of tea drinkers. In 2016, Americans drank 84 billion cups of tea; that is 260 cups for every man, woman and child. Of the 3.8 billion gallons thus consumed, about 80% was black tea, 16% was green tea, while the rest was either Oolong, white or dark tea. Unlike the rest of the world, Americans like their tea cold. About 80 percent of the tea consumed on a daily basis is chilled. However, hot tea appears to be gaining in popularity with the health conscious. The Tea Association of the USA reports (http://nnw.fm/t7Rn7) that ‘total category sales for hot tea have increased more than 15% over the last 5 years…’ The Association ‘anticipates strong, continuous growth, with a CAGR of 4-6% (coming) from all segments driven by variety, convenience, health benefits, sustainability, availability, continued innovation and the discovery of unique, flavorful and high-end specialty teas’.
Lexaria’s acquisition of Poviva Tea, LLC, announced on November 2 (http://nnw.fm/CQpn9), gives Lexaria a toehold in this vast $7 billion plus market and consolidates ownership of Poviva Tea, LLC as a wholly owned Lexaria Bioscience subsidiary. The move also simplifies future operations and certain intellectual property ownership issues. In addition, Lexaria announced that, effectively immediately, PoViva Tea will now operate with the trade name of ViPovaTM Tea. The company believes that the rebranding will ensure long-term protection of intellectual rights. At the center of this strategy is Lexaria’s patented DehydraTECH technology, which is focused on the improving the delivery of many commonly used Active Pharmaceutical Ingredients (APIs). The DehydraTECH technology provides an additional layer of effectiveness, designed to harmonize with the intellectual property of third parties, which both patented and generic API substances can employ. Lexaria’s long term strategy is to partner with the world’s leading firms as they deliver best-of-class products to their existing large consumer groups.
Lexaria is constantly exploring ways to make the health benefits of cannabinoids (CBD) more accessible and the company’s DehydraTECH technology is a way to do so. Many hemp products on the market are simply mixtures of hemp oil with other ingredients. However, Lexaria’s patented methodology infuses organically sourced hemp oil into the molecules of other substances, such as lipids, which, as it turns out, form the basis of the human endocannabinoid system. Consequently, the body better absorbs products employing the technology.
Presently, Lexaria is the only company in the world that has been awarded a patent for the improved (oral or ingestible, including pills) delivery of all non-psychoactive cannabinoids. Patents have been awarded in the U.S. and Australia and are pending in 40 more countries. This puts the company in the unusually advantageous position of owning proprietary technology that can deliver a vast range of non-psychoactive cannabinoid-based drugs.
Lexaria is already applying its innovative delivery technology to the range of ViPova black teas, which come from the province of Yunnan in China and are supplemented with hemp oil infused within dried evaporated non-fat milk. Introduced in January 2015, the tea is available in a variety of varieties and flavors. The ViPova range runs from 8 to 32 bag portions and varieties include Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light.
For more information, visit the company’s website at www.LexariaEnergy.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼